KPS-0373

· Kissei Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

9 regulatory and trial events tracked for KPS-0373, covering 2010-02-03 to 2025-06-27. Get the full timeline:

Most recent: Clinical Trial Update: Confirmatory Study 3 of KPS-0373 in Patients With Spinocerebellar Degeneration [Phase 3]